BamSEC and AlphaSense Join Forces
Learn More

Lipella Pharmaceuticals Inc.

NASDAQ: LIPO    
Share price (12/31/24): $3.05    
Market cap (12/31/24): $3.687 million

Indentures Filter

EX-4.2
from 8-K 5 pages Irrevocable Proxy and Power of Attorney
12/34/56
EX-4.1
from 8-K 11 pages Lipella Pharmaceuticals Inc. Form of Common Stock Purchase Warrant
12/34/56
EX-4.2
from 8-K 19 pages Placement Agent Common Stock Purchase Warrant Lipella Pharmaceuticals Inc
12/34/56
EX-4.1
from 8-K 18 pages Prefunded Common Stock Purchase Warrant Lipella Pharmaceuticals Inc
12/34/56
EX-4.4
from S-8 17 pages Lipella Pharmaceuticals Inc. Amended and Restated 2020 Stock Incentive Plan
12/34/56
EX-4.5
from S-3 39 pages Lipella Pharmaceuticals Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 39 pages Lipella Pharmaceuticals Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Senior Debt Securities
12/34/56
EX-4.3
from 8-K 19 pages Placement Agent Common Stock Purchase Warrant Lipella Pharmaceuticals Inc
12/34/56
EX-4.2
from 8-K 19 pages Common Stock Purchase Warrant Lipella Pharmaceuticals Inc
12/34/56
EX-4.1
from 8-K 19 pages Pre-Funded Common Stock Purchase Warrant Lipella Pharmaceuticals Inc
12/34/56
EX-4.3
from S-8 POS 17 pages Lipella Pharmaceuticals Inc. Amended and Restated 2020 Stock Incentive Plan
12/34/56
EX-4.2
from 10-K 3 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1/A 11 pages Underwriter’s Warrant for the Purchase of [●] Shares of Common Stock of Lipella Pharmaceuticals Inc
12/34/56
EX-4.2
from S-1/A 11 pages Underwriter’s Warrant for the Purchase of [●] Shares of Common Stock of Lipella Pharmaceuticals Inc
12/34/56